celecoxib and arachidonyltrifluoromethane

celecoxib has been researched along with arachidonyltrifluoromethane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anwar, K; Carsons, SE; Eapen, S; Jaber, NL; Littlefield, MJ; Reiss, AB; Sohn, A; Voloshyna, I; Wirkowski, PA	1

Other Studies

1 other study(ies) available for celecoxib and arachidonyltrifluoromethane

Article	Year
COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells. Lipids, 2011, Volume: 46, Issue:2 Topics: Arachidonic Acids; CD36 Antigens; Celecoxib; Cell Culture Techniques; Cells, Cultured; Cholesterol; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Foam Cells; Gene Expression; Gene Silencing; Humans; Monocytes; Phospholipases A2, Cytosolic; Plaque, Atherosclerotic; Pyrazoles; Scavenger Receptors, Class A; Sulfonamides	2011

Article

Year

COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.

Lipids, 2011, Volume: 46, Issue:2

Topics: Arachidonic Acids; CD36 Antigens; Celecoxib; Cell Culture Techniques; Cells, Cultured; Cholesterol; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Foam Cells; Gene Expression; Gene Silencing; Humans; Monocytes; Phospholipases A2, Cytosolic; Plaque, Atherosclerotic; Pyrazoles; Scavenger Receptors, Class A; Sulfonamides

2011